🚀 Dive into breakthroughs and bold investments driving the UK #biotech sector’s £3.5 billion success in the annual UK biotech financing 2024 report ➡️ 📣 In the report, the @BIA_UK highlights the UK biotech sector's resilience, #innovation, global appeal, and its ability to stay competitive on the global stage 🌍 Key Highlights from the report include: 🔵 £2.06 billion secured through venture capital funding across 111 deals. 🔵 North American investors accounted for 26% of UK biotech VC #Investments, marking their largest share since 2021. Explore the latest insights in the annual UK biotech financing 2024 report ➡️ #InvestinBiotech

Thanks to the @BIA_UK sustained campaigning, the @UKLabour Party has committed to maintaining the rates of R&D tax relief—a major boost for innovation ➡️ This announcement follows a letter signed by 150 industry CEOs, led by BIA CEO Steve Bates OBE FMedSci, urging the Chancellor @RachelReevesMP to take action. What this means for biotech:⤵️ ✅ Stability & reassurance for the sector ✅ Recognition of HMRC challenges & commitment to improvements ✅ A stronger foundation for future growth 👉 Read our Q4 Influencing & shaping our sector report ➡️

The @BIA_UK was delighted to attend the @GenomicsEngland parliamentary reception in the UK House of Lords last night. It was great to hear from speakers including Baroness @nicolablackwood and Baroness Gillian Merron about the potential of genomics to transform #healthcare for patients across the UK We look forward to continuing to work closely with #GenomicsEngland and our members working in this space to drive forward innovation in #Genomic technologies.

Join us for an insightful discussion on how the CEO/Investor relationship shapes board and executive representation in biotech at our #WomeninBiotech event in 📍#Cambridge ➡️ This is an opportunity for inspiring biotech entrepreneurs to hear from industry leaders and gain valuable perspectives on diversity and leadership in #LifeSciences 🧬 🔹 Anne Horgan (nee Nguyen), Partner, @cic_vc 🔹 Elisa Petris, Partner, @SynconaLtd Investment Management 🔹 Lisa Deschamps, CEO, @AviadoBio 🔹 Natalie Pankova, PhD, Managing Director, @deeptechventure,

Exciting news in 💊 #CancerTreatment! 🎯 @o2hgroup have announced their investment in Stratosvir Limited to advance their viral immunotherapy for late-stage cancer 👏 ➡️ 💉 Unlike traditional therapies that require direct tumour injections, Stratosvir’s intravenous delivery method allows for multiple doses, increased accessibility, and greater impact. 🌍 Beyond prostate cancer, this breakthrough has the potential to transform cancer treatment as we know it🚀

📢 Last night, we relaunched the #APPGforLifeSciences at a parliamentary reception with our industry & third-sector partners. 🏥 MPs explored UK life sciences innovation, including @nanopore’s cutting-edge sequencing tech. 🔬 Inspiring speeches from Chris Whitty (@CMO_England) & @kitmalthouse highlighted the UK’s strengths & opportunities ahead. We look forward to championing policies & investment with this new group to help the UK life sciences ecosystem thrive. Collaboration is key.💡🚀 #Innovation #UKLeadership #lifesciences @ABPI_UK @AMRC @TheBHF @acmedsci @CR_UK @BIVDA @VersusArthritis @Sadik4Pharmacy @PippaHeylings @DelythMorgan

🎉 It’s National Apprenticeship Week! 🙌 ➡️ We’re excited to share an insightful #blog from Amy Turner, Business Development Professional at @NortheasternLDN, on how apprenticeships drive real ROI for your organisation 🤝 🔗 Read the full blog at the link above! #NationalApprenticeshipWeek #NAW2025

RT @ABPI_UK: Great to have a coalition of support for life sciences in the UK @kitmalthouse @pippaheylings @BIA_UK @CMO_England #APPGforLif…

📣 In this week's CEO blog, Steve Bates OBE discusses key developments shaping the industry, including sustainable medicine manufacturing, #AI-driven healthcare advancements and much more ➡️ #CEOblog

📣 This week, BIA submitted our Spending Review entry, highlighting key priorities to drive 📈 #EconomicGrowth ➡️ With #LifeSciences recognised as a priority sector under the Industrial Strategy, our focus is on: 🔹 Innovation 🔹 Investment 🔹 Regulation 🔹 Skills & Talent 🔹 Trade & Partnerships 🔹 Infrastructure Through strengthening regulation, expanding access to talent, and driving investment, we hope to accelerate innovation and solidify the UK’s position as a global leader in life sciences. 🚀

🔎 We’re excited to feature Autolus Therapeutics in the 🧬 UK #biotech financing report, highlighting their incredible achievements in advancing CAR T cell therapies for #Oncology and #AutoimmuneDiseases ➡️ With a £434m NASDAQ follow-on offering, Autolus is accelerating the commercialisation of obe-cel and pioneering cutting-edge treatments that have the potential to transform patient outcomes.👏 📖 Read the full case study in the #UK biotech financing report ➡️ Special thanks to Chris Williams, CBO, Autolus Therapeutics 🙌 #InvestinBiotech

Discover how BIA is driving impact in our sector ➡️ At the first Life Sciences Council meeting under the new Labour Government, key leaders from both government and industry came together to discuss priorities for the UK’s biotech sector. BIA CEO Steve Bates and @Bicycle_tx CEO Kevin Lee Lee were part of the discussion, advocating for better access to finance and support for scaling UK biotech. Kevin, awarded Entrepreneur of the Year by BIA, emphasised, "Membership of BIA gives us a strong united voice, and opens opportunities to meet with policymakers to support our sector." 👉 Read our Q4 Influencing & shaping our sector report ➡️

The Oxford Brookes Scale Up Network is launching a cohort for bioscience businesses looking to grow sustainably 🍃 ✨ Expert-led sessions on leadership, company culture & employee engagement 📈 6 months of support to implement real change & scale successfully 🔗 Sign up here:

🚀 We’re excited to feature Cambridge Innovation Capital and its work in supporting #Innovation within the Cambridge ecosystem in this year’s UK biotech financing report ➡️ With the Chancellor’s plans to develop Europe’s #SiliconValley between 📍#Oxford and #Cambridge, the future looks bright for 🧬 #UKbiotech. It’s inspiring to see the sector thriving, and we look forward to the groundbreaking research and innovation that will continue to strengthen its position on the global stage 🌍 Special thanks to Anne Horgan (nee Nguyen) for her thoughts 🙌 #InvestinBiotech

RT @TheBusinessMag: UK biotech accelerates growth with £3.5bn investment surge 🧬🪙 @BIA_UK #biotech #technology #innovation #finance #inves…

RT @mrtejkohli: 📈 According to @BIA_UK, the UK biotech sector raised £3.5bn in 2024, marking a 94 per cent increase from 2023. 💡 The impor…

As Donald Trump returns to The White House, the #biotech industry is assessing what his presidency means for 💹 #Investment and innovation. With the UK’s #LifeSciences 🍃 sector gaining strength, could this be the moment to turn uncertainty into opportunity? 🔍 �� In this blog, Albert MK, Media and Communications Executive at the @BIA_UK, delves into insights from the BIA’s pre-Gala Dinner event, where industry leaders explored the impact of Trump’s presidency on 🧬 #UKbiotech and the opportunities it presents.